During the reinspection, the production conditions at the Company’s 11 sites manufacturing sterile and non-sterile medicinal products, including four new production sites, were audited.
Farmak JSC is expecting the inspection report within the term established by the Croatian laws.
The positive result of the reinspection will facilitate Farmak’s expansion to the European markets.
According to the notice of the State Service of Ukraine on Medicines and Drug Control, “The passing of such procedure and the extension of the GMP certificate validity for Farmak, a Ukrainian manufacturer, is a confirmation of the quality of medicinal products manufactured by the Company, as well as their marketing authorizations”.
Previous inspections by HALMED, the Croatian regulatory agency, were conducted at Farmak JSC in 2015. Following the inspections, the Company obtained the corresponding GMP certificates.
The increase is expected from sales both in Ukraine and on export markets. This year, according to the Company’s forecasts, the share of exports will be 33%. In 2017, Farmak’s share of sales on foreign markets was 31%. According to the results of the first half of 2018, Farmak JSC’s export volume increased by 13% […]
On 9 September, Andriyivskyy Descent in Kyiv brought together partners from various business areas, creative figures, guests and friends to celebrate its anniversary. Farmak JSC was a partner and co-organizer of the holiday of pleasant emotions with breath of history. Within the innovative part of the event, Farmak JSC installed diagnostic tents and a fish-e...
The Company delivered special bags for emergency rescue teams of Shostka emergency (ambulance) station. Vasyl Kushniruk, Head of API Department of Farmak JSC, provided bags for the emergency teams. “Farmak is a socially responsible company striving to help all those in need”, he stressed. Anatoliy Aleksandrenko, Director of Sumy Regional Center for Emergency...